Home / News


HoloMonitor M4 with logo

CEO interview in BioStock

In the article published today by BioStock, the company's CEO Peter Egelberg comments on the developments during the past autumn.
Learn more
Single-cell analysis using supercomputers

New CEO commentary: “The Single-Cell Revolution”

PHI’s CEO and founder Peter Egelberg comments the recently published innovation report from the UN agency World Intellectual Property Organization.
Learn more
label-free adherent cell tracking

Interim Report 2 2019/20

Interim Report 2 (2019-05-01 – 2019-10-31) from Phase Holographic Imaging.
Learn more

Growing & Analyzing Cells at their Best

BioSpherix and Phase Holographic Imaging (PHI) have teamed up to support researchers in their ambition to grow and analyze cells in a cell-friendly environment, without cell disturbing factors like labels, stains and temperature fluctuations.
Learn more

Advancing methods for the analysis of glioblastoma cell motion using quantitative time-lapse holographic imaging and cellular tomography

The Label-free cell analysis technology, using HoloMonitor cell-based assays, is an easy way to capture cell events and more information from individual cells.
Learn more

New SelectScience eBook helps scientists choose the best cell imaging technology

A new cell imaging technology guide has been launched by leading independent science publisher SelectScience® to help scientists find the best equipment for their applications.
Learn more

Interim Report 1 2019/20

Interim Report 1 (2019-05-01 – 2019-07-31) from Phase Holographic Imaging.
Learn more

Årsredovisning 2018/19

Styrelsen och verkställande direktören för Phase Holographic Imaging PHI AB (publ), organisationsnummer 556542-7811 och med säte i Lund, avger härmed årsredovisning för räkenskapsåret 1 maj 2018 – 30 april 2019.  
Learn more

Kallelse till årsstämma i Phase Holographic Imaging PHI AB (publ)

Aktieägarna i Phase Holographic Imaging PHI AB (publ), 556542-7811, kallas härmed till årsstämma tisdagen den 15 oktober 2019 kl. 17.00 i bolagets lokaler, Scheelevägen 22 i Lund. Rätt att delta och anmälan Aktieägare som önskar delta i bolagsstämman ska vara införd i den av Euroclear Sweden AB förda aktieboken onsdagen den 9 oktober 2019, och …
Learn more
PHI building

US National Institutes of Health intends to purchase HoloMonitor

The US National Institute of Aging intends to purchase a HoloMonitor instrument from Phase Holographic Imaging. The National Institute of Aging is part of the National Institutes of Health (NIH), a government agency to promote medical research.
Learn more